Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;31(3):426-434.
doi: 10.21147/j.issn.1000-9604.2019.03.04.

Incidence and mortality of esophagus cancer in China, 2008 - 2012

Affiliations

Incidence and mortality of esophagus cancer in China, 2008 - 2012

Yutong He et al. Chin J Cancer Res. 2019 Jun.

Abstract

Objective: To analyze the incidence and mortality rates of esophagus cancer in China from 2008 to 2012.

Methods: Incident and mortality cases of esophagus cancer were retrieved from the National Central Cancer Registry (NCCR) database collecting from 135 cancer registries in China during 2008-2012. The incidence and mortality rates of esophagus cancer were calculated by area (urban/rural), region (eastern, middle, western), gender and age group (0, 1-4, 5-84 by 5 years and 85+ years). China census in 2000 and Segi's world population were applied for age-standardized rates. Joinpoint model was used for time-trend analysis.

Results: The crude incidence rate of esophagus cancer was 22.57/100,000. The age-standardized incidence rates by China standard population (ASIRC) and by world standard population (ASIRW) were 14.58/100,000 and 14.80/100,000, respectively. The crude mortality rate of esophagus cancer was 17.19/100,000. The age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 10.80/100,000 and 10.86/100,000 respectively. Incidence and mortality rates of esophagus cancer were higher in males than in females and higher in rural areas than in urban areas. The crude incidence rate in middle areas was the highest among all areas, followed by western areas and eastern areas. The age-specific incidence rate of esophagus cancer was relatively low in age groups before 40 years old and then increased after 45 years old. It peaked in the age group of 80-84 years. The patterns of age-specific mortality rates of esophagus cancer were close to those of age-specific incidence rates. The ASIRC of esophagus cancer decreased dramatically by 29.87% between 2003 and 2012, from 14.33/100,000 to 10.05/100,000. The esophagus cancer incidence rate decreased by 3.76% per year (P>0.05). The mortality rate of esophagus cancer decreased annually over the decades from 2003 to 2012 in China (P>0.05). In females, the annual percentage change (APC) of mortality rate was -5.43% [95% confidence intervals (95% CI): -6.50%, -4.30%] (P<0.05) and the mortality rate of esophagus cancer in rural females was statistically significant (APC: -3.20%, 95% CI: -4.20%, -2.20%) (P<0.05).

Conclusions: The focus of prevention and treatment for esophagus cancer is strengthening primary prevention of esophageal cancer, and promoting esophagus cancer secondary prevention to reduce incidence and mortality rates of esophagus cancer, prolong survival rate of patients and decline the burden of esophagus cancer in China.

Keywords: China; Esophagus cancer; cancer registration; incidence; mortality.

PubMed Disclaimer

Figures

1
1
Age-specific incidence of esophagus cancer in urban and rural areas in China, 2008−2012.
2
2
Age-specific incidence of esophagus cancer in different regions in China, 2008−2012.
3
3
Temporal trend of age-standardized incidence rates by China population (ASIRC) of esophagus cancer in China, 2003−2012.
4
4
Age-specific mortality of esophagus cancer in urban and rural areas in China, 2008−2012.
5
5
Age-specific mortality of esophagus cancer in different regions in China, 2008−2012.
6
6
Temporal trend of age-standardized mortality rates by Chinese standard population (ASMRC) of esophagus cancer in China, 2003−2012.

References

    1. Bray F, Ferlay J, Soerjomataram I, et al Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Zheng R, Sun K, Zhang S, et al Report of cancer epidemiology in China, 2015. Zhonghua Zhong Liu Za Zhi. 2019;41:19–28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005. - DOI - PubMed
    1. Parkin DM The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6:603–12. doi: 10.1038/nrc1948. - DOI - PubMed
    1. Curade MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC Press, 2007.

    1. Chen W, Zheng R, Zhang S, et al Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71. doi: 10.1016/j.canlet.2017.04.024. - DOI - PubMed

LinkOut - more resources